Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sembiosys Genetics Inc. SBIYF

Healthcare Biotechnology
"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."


GREY:SBIYF - Post by User

Sembiosys Genetics Inc. > This is the Vancouver Conference 2012
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by AlfredFettucineon Feb 03, 2012 10:24pm
191 Views
Post# 19489375

RE: This is the Vancouver Conference 2012

RE: This is the Vancouver Conference 2012

Something has got to give. Hopefully this will push it forward. SP is being held down quite nicely for reasons not known here. Sooner or later, up and away we'll go.

 

AF

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities